Literature DB >> 12391548

Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis.

Henning Danz1, Stefka Stoyanova, Olivier A R Thomet, Hans-Uwe Simon, Gerd Dannhardt, Holger Ulbrich, Matthias Hamburger.   

Abstract

The indolo[2,1- b]quinazoline alkaloid tryptanthrin has previously been identified as the cyclooxygenase-2 (COX-2) inhibitory principle in the extract ZE550 prepared from the medicinal plant Isatis tinctoria (Brassicaceae). We here investigated the potential inhibitory activity of tryptanthrin and ZE550 on COX-2, COX-1 in cellular and cell-free systems. A certain degree of selectivity towards COX-2 was observed when COX-1-dependent formation of thromboxane B(2) (TxB(2)) in HEL cells and COX-2-dependent formation of 6-ketoprostaglandin F(1alpha) (6-keto-PGF(1alpha)) in Mono Mac 6 and RAW 264.7 cells were compared. Preferential inhibition of COX-2 by two orders of magnitude was found in phorbol myristate acetate (PMA) activated bovine aortic coronary endothelial cells (BAECs). Assays with purified COX isoenzymes from sheep confirmed the high selectivity towards COX-2. The leukotriene B(4) (LTB(4)) release from calcium ionophore-stimulated human granulocytes (neutrophils) was used as a model to determine 5-lipoxygenase (5-LOX) activity. Tryptanthrin and the extract ZE550 inhibited LTB(4) release in a dose dependent manner and with a potency comparable to that of the clinically used 5-LOX inhibitor zileuton.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391548     DOI: 10.1055/s-2002-34922

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  Analysis of the extracts of Isatis tinctoria by new analytical approaches of HPLC, MS and NMR.

Authors:  Jue Zhou; Fan Qu
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

Review 2.  Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Authors:  Hayamitsu Adachi; Koichi Nakae; Shuichi Sakamoto; Chisato Nosaka; Sonoko Atsumi; Masabumi Shibuya; Nobuaki Higashi; Motowo Nakajima; Tatsuro Irimura; Yoshio Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

Review 3.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

4.  On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivo.

Authors:  C Pergola; B Jazzar; A Rossi; H Northoff; M Hamburger; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2.

Authors:  Bo Zhang; Chang-Liang Wang; Wen-Hua Zhao; Ming Lv; Chun-Ying Wang; Wei-Xia Zhong; Wu-Yuan Zhou; Wen-Sheng Yu; Yan Zhang; Sheng Li
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia K562 cell line in vitro.

Authors:  Shan Miao; Xiaopeng Shi; Hai Zhang; Siwang Wang; Jiyuan Sun; Wei Hua; Qing Miao; Yong Zhao; Caiqin Zhang
Journal:  Int J Mol Sci       Date:  2011-06-10       Impact factor: 5.923

7.  Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation.

Authors:  Tobias Lotts; Kathrin Kabrodt; Johanna Hummel; Dorit Binder; Ingo Schellenberg; Sonja Ständer; Konstantin Agelopoulos
Journal:  Acta Derm Venereol       Date:  2020-05-11       Impact factor: 3.875

8.  Study on pharmacokinetics and tissue distribution of single dose oral tryptanthrin in Kunming mice by validated reversed-phase high-performance liquid chromatography with ultraviolet detection.

Authors:  Xiaoyan Zhang; Jie Xia; Wenjing Zhang; Yao Luo; Wenbo Sun; Wei Zhou
Journal:  Integr Med Res       Date:  2017-05-25

Review 9.  Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update.

Authors:  Yuva Bellik; Laïd Boukraâ; Hasan A Alzahrani; Balkees A Bakhotmah; Fatiha Abdellah; Si M Hammoudi; Mokrane Iguer-Ouada
Journal:  Molecules       Date:  2012-12-27       Impact factor: 4.411

Review 10.  Cancer Chemoprevention: A Strategic Approach Using Phytochemicals.

Authors:  Mohan Shankar G; Mundanattu Swetha; C K Keerthana; Tennyson P Rayginia; Ruby John Anto
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.